Ignacio M. Helbling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ignacio M. Helbling has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Julio A. Luna
INTEC (Universidad Nacional del Litoral - CONICET), 3450 Güemes, 3000, Santa Fe, Argentina
10 shared publicationsJuan C.D. Ibarra
Fine Chemical Laboratory, Institute of Technological Development for the Chemical Industry (INTEC), National University of Litoral and the National Council of Scientific and Technical Research (UNL-CONICET), Santa Fe, Argentine
3 shared publicationsMaría I. Cabrera
3 shared publicationsDiana A. Estenoz
INTEC (Universidad Nacional del Litoral - CONICET), 3450 Güemes, 3000, Santa Fe, Argentina
2 shared publications- Federico Karp
Centro de Investigación y Desarrollo en Fermentaciones Industriales (CINDEFI), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
2 shared publications Juan C. D. Ibarra
Laboratorio de Química Fina, Instituto de Desarrollo Tecnológico para la Industria Química (INTEC), Universidad Nacional del Litoral and Consejo Nacional de Investigaciones Científicas y Técnicas (UNL-CONICET), CCT CONICET-SANTA FE, Ruta Nacional 168, Paraje El Pozo, 3000, Santa Fe, Argentina
2 shared publications
Latest Publications
- 1 October 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (5) , 1255-1266
Design and evaluation of a recyclable intravaginal device made of ethylene vinyl acetate copolymer for bovine estrus synchronization
In bovine estrus synchronization, intravaginal devices made of silicone are used to administer exogenous progesterone with the aim of maintain plasmatic levels above 2 ng ml(-1)during the treatment. After their use, devices must be discarded. There is an important concern on the environmental impact of the disposal of these used products due mainly to the non-degradability of the silicone and to the residual content of the hormone. Different alternatives are being studied, and the use of ecological materials appears as the more important. The objective of the present contribution was to design and evaluate a recyclable intravaginal prototype using ethylene vinyl acetate copolymer (EVA). Devices were fabricated by an injection-molding technique and characterized in terms of dimensions, loading efficiency, release rate, and wing tension. An analysis was first conducted to compare three different matrices and two supports. Secondly, the best candidate prototype was assayed in both beef and dairy cattle. Finally, used matrices were recycled measuring the progesterone content in the resulting devices and testing them in vitro. According to release tests, no differences were observed between the three matrices both in vitro and in vivo. On the contrary, a better performance was achieved when a support with a more flexible Y shape was used in comparison with a rigid T geometry. Successful results were observed in non-lactating cows, with plasma concentrations above the threshold value defined for the synchronization therapy. However, lower progesterone levels resulted when devices were tested in animals with large milk production. By last, recycled matrices presented a similar initial content and in vitro release rate than original matrices. These findings could open the possibility to use recyclable EVA devices as an alternative to the non-degradable silicone intravaginal inserts. Future research must be carried out to optimize the performance of the recycled matrices in dairy cattle. Modifications of the release surface and/or the initial loading can give a solution to the lower values observed in these animals. Graphical abstract
- 1 October 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (5) , 1255-1266
Design and evaluation of a recyclable intravaginal device made of ethylene vinyl acetate copolymer for bovine estrus synchronization
In bovine estrus synchronization, intravaginal devices made of silicone are used to administer exogenous progesterone with the aim of maintain plasmatic levels above 2 ng ml(-1)during the treatment. After their use, devices must be discarded. There is an important concern on the environmental impact of the disposal of these used products due mainly to the non-degradability of the silicone and to the residual content of the hormone. Different alternatives are being studied, and the use of ecological materials appears as the more important. The objective of the present contribution was to design and evaluate a recyclable intravaginal prototype using ethylene vinyl acetate copolymer (EVA). Devices were fabricated by an injection-molding technique and characterized in terms of dimensions, loading efficiency, release rate, and wing tension. An analysis was first conducted to compare three different matrices and two supports. Secondly, the best candidate prototype was assayed in both beef and dairy cattle. Finally, used matrices were recycled measuring the progesterone content in the resulting devices and testing them in vitro. According to release tests, no differences were observed between the three matrices both in vitro and in vivo. On the contrary, a better performance was achieved when a support with a more flexible Y shape was used in comparison with a rigid T geometry. Successful results were observed in non-lactating cows, with plasma concentrations above the threshold value defined for the synchronization therapy. However, lower progesterone levels resulted when devices were tested in animals with large milk production. By last, recycled matrices presented a similar initial content and in vitro release rate than original matrices. These findings could open the possibility to use recyclable EVA devices as an alternative to the non-degradable silicone intravaginal inserts. Future research must be carried out to optimize the performance of the recycled matrices in dairy cattle. Modifications of the release surface and/or the initial loading can give a solution to the lower values observed in these animals. Graphical abstract
- 1 April 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 234, 115922
An analysis of the microencapsulation of ceftiofur in chitosan particles using the spray drying technology
- 1 April 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 234, 115922
An analysis of the microencapsulation of ceftiofur in chitosan particles using the spray drying technology
- 20 February 2018
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (3) , 66
Preparation of TPP-crosslinked chitosan microparticles by spray drying for the controlled delivery of progesterone intended for estrus synchronization in cattle
Planned reproduction in cattle involves regulation of estrous cycle and the use of artificial insemination. Cycle control includes the administration of exogenous progesterone during 5–8 days in a controlled manner allowing females to synchronize their ovulation. Several progesterone delivery systems are commercially available but they have several drawbacks. The aim of the present contribution was to evaluate chitosan microparticles entrapping progesterone as an alternative system.
- 20 February 2018
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (3) , 66
Preparation of TPP-crosslinked chitosan microparticles by spray drying for the controlled delivery of progesterone intended for estrus synchronization in cattle
Planned reproduction in cattle involves regulation of estrous cycle and the use of artificial insemination. Cycle control includes the administration of exogenous progesterone during 5–8 days in a controlled manner allowing females to synchronize their ovulation. Several progesterone delivery systems are commercially available but they have several drawbacks. The aim of the present contribution was to evaluate chitosan microparticles entrapping progesterone as an alternative system.
- Open Access
- 2 March 2017
- Published by Juniper Publishers in Organic & Medicinal Chemistry International Journal
- Vol. 1 (4)
The Role of Micro fluidic Systems in Biological and Medical Sciences
- 2 March 2017
- Published by Juniper Publishers in Organic & Medicinal Chemistry International Journal
- Vol. 1 (4)
Open AccessThe Role of Micro fluidic Systems in Biological and Medical Sciences
- 20 April 2016
- Published by Springer Nature in The AAPS Journal
- Vol. 18 (4) , 960-971
The Use of Cellulose Membrane to Eliminate Burst Release from Intravaginal Rings
Burst release was observed when ethylene vinyl acetate copolymer (EVA) intravaginal rings were tested for progesterone release in our previous work (Helbling et al. Pharm Res. 31(3):795-808, 2014). Burst release is undesirable in controlled delivery devices because release is uncontrollable and higher levels of active pharmaceutical ingredient could lead to the occurrence of adverse effect. The present contribution is about the use of membranes to coat EVA rings to eliminate burst release. Physicochemical state of progesterone in uncoated rings and the solubility and diffusion coefficient in membrane were studied. Hormone delivery from several rings of different sizes was compared. A mathematical model was used to analyze the effects of membrane properties on delivery rate. No chemical interactions were detected between hormone and polymer. Hormone was mainly forming amorphous aggregates inside rings, and migration to membrane was not observed during storage. Diffusion coefficient was smaller in membrane (similar to 10(-8) cm(2) s(-1)) than in matrix (similar to 10(-7) cm(2) s(-1)). Zero-order release kinetics were obtained for coated rings, and release rate decreases as the thickness of the coat increases. Cellulose membrane successfully eliminates burst release and controls the delivery from EVA rings. The equations developed can be used to determine the appropriate coat thickness to produce specific release rate.
- 20 April 2016
- Published by Springer Nature in The AAPS Journal
- Vol. 18 (4) , 960-971
The Use of Cellulose Membrane to Eliminate Burst Release from Intravaginal Rings
Burst release was observed when ethylene vinyl acetate copolymer (EVA) intravaginal rings were tested for progesterone release in our previous work (Helbling et al. Pharm Res. 31(3):795-808, 2014). Burst release is undesirable in controlled delivery devices because release is uncontrollable and higher levels of active pharmaceutical ingredient could lead to the occurrence of adverse effect. The present contribution is about the use of membranes to coat EVA rings to eliminate burst release. Physicochemical state of progesterone in uncoated rings and the solubility and diffusion coefficient in membrane were studied. Hormone delivery from several rings of different sizes was compared. A mathematical model was used to analyze the effects of membrane properties on delivery rate. No chemical interactions were detected between hormone and polymer. Hormone was mainly forming amorphous aggregates inside rings, and migration to membrane was not observed during storage. Diffusion coefficient was smaller in membrane (similar to 10(-8) cm(2) s(-1)) than in matrix (similar to 10(-7) cm(2) s(-1)). Zero-order release kinetics were obtained for coated rings, and release rate decreases as the thickness of the coat increases. Cellulose membrane successfully eliminates burst release and controls the delivery from EVA rings. The equations developed can be used to determine the appropriate coat thickness to produce specific release rate.
- 18 April 2014
- Published by Wiley
- p. 225-242
Mathematical Modeling of Drug Delivery from Silicone Devices Used in Bovine Estrus Synchronization
- 18 April 2014
- Published by Wiley
- p. 225-242
Mathematical Modeling of Drug Delivery from Silicone Devices Used in Bovine Estrus Synchronization
- 18 October 2013
- Published by Springer Nature in Pharmaceutical Research
- Vol. 31 (3) , 795-808
The Optimization of an Intravaginal Ring Releasing Progesterone Using a Mathematical Model
Progering® is the only intravaginal ring intended for contraception therapies during lactation. It is made of silicone and releases progesterone through the vaginal walls. However, some drawbacks have been reported in the use of silicone. Therefore, ethylene vinyl acetate copolymer (EVA) was tested in order to replace it. EVA rings were produced by a hot-melt extrusion procedure. Swelling and degradation assays of these matrices were conducted in different mixtures of ethanol/water. Solubility and partition coefficient of progesterone were measured, together with the initial hormone load and characteristic dimensions. A mathematical model was used to design an EVA ring that releases the hormone at specific rate. An EVA ring releasing progesterone in vitro at about 12.05 ± 8.91 mg day−1 was successfully designed. This rate of release is similar to that observed for Progering®. In addition, it was observed that as the initial hormone load or ring dimension increases, the rate of release also increases. Also, the device lifetime was extended with a rise in the initial amount of hormone load. EVA rings could be designed to release progesterone in vitro at a rate of 12.05 ± 8.91 mg day−1. This ring would be used in contraception therapies during lactation. The use of EVA in this field could have initially several advantages: less initial and residual hormone content in rings, no need for additional steps of curing or crosslinking, less manufacturing time and costs, and the possibility to recycle the used rings.
- 18 October 2013
- Published by Springer Nature in Pharmaceutical Research
- Vol. 31 (3) , 795-808
The Optimization of an Intravaginal Ring Releasing Progesterone Using a Mathematical Model
Progering® is the only intravaginal ring intended for contraception therapies during lactation. It is made of silicone and releases progesterone through the vaginal walls. However, some drawbacks have been reported in the use of silicone. Therefore, ethylene vinyl acetate copolymer (EVA) was tested in order to replace it. EVA rings were produced by a hot-melt extrusion procedure. Swelling and degradation assays of these matrices were conducted in different mixtures of ethanol/water. Solubility and partition coefficient of progesterone were measured, together with the initial hormone load and characteristic dimensions. A mathematical model was used to design an EVA ring that releases the hormone at specific rate. An EVA ring releasing progesterone in vitro at about 12.05 ± 8.91 mg day−1 was successfully designed. This rate of release is similar to that observed for Progering®. In addition, it was observed that as the initial hormone load or ring dimension increases, the rate of release also increases. Also, the device lifetime was extended with a rise in the initial amount of hormone load. EVA rings could be designed to release progesterone in vitro at a rate of 12.05 ± 8.91 mg day−1. This ring would be used in contraception therapies during lactation. The use of EVA in this field could have initially several advantages: less initial and residual hormone content in rings, no need for additional steps of curing or crosslinking, less manufacturing time and costs, and the possibility to recycle the used rings.
- 1 February 2012
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 423 (2) , 240-246
Application of the Refined Integral Method in the mathematical modeling of drug delivery from one-layer torus-shaped devices
- 1 February 2012
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 423 (2) , 240-246
Application of the Refined Integral Method in the mathematical modeling of drug delivery from one-layer torus-shaped devices
- 9 October 2011
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 44 (3) , 288-298
Mathematical modeling of drug delivery from one-layer and two-layer torus-shaped devices with external mass transfer resistance
- 9 October 2011
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 44 (3) , 288-298
Mathematical modeling of drug delivery from one-layer and two-layer torus-shaped devices with external mass transfer resistance
- 1 February 2011
- Published by Elsevier in Journal of Controlled Release
- Vol. 149 (3) , 258-263
Mathematical modeling of drug delivery from torus-shaped single-layer devices
- 1 February 2011
- Published by Elsevier in Journal of Controlled Release
- Vol. 149 (3) , 258-263
Mathematical modeling of drug delivery from torus-shaped single-layer devices